NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Coforge's FY27 Organic Revenue Growth Faces Headwinds

Coforge's organic revenue growth for the fiscal year 2027 (FY27) is likely to be impacted by the exit of its low-margin India portfolio and a weak exit runrate in its largest vertical, Banking, Financial Services, and Insurance (BFS). Despite this, the company has a healthy next-12-month orderbook, which has seen a 16% year-over-year (YoY) increase. The agreements with UK public sector clients not yet included in the order book could lead to a healthy revenue recovery from the second quarter of FY27.

Guidance and Margin Improvements

Coforge has provided strong guidance for FY27, including an EBITDA margin of 20.5%-21% and an EBIT margin of 15.5% (16.5%-17% organic). This implies a healthy margin improvement of approximately 110 basis points (bps) YoY. However, our research team has cut the organic revenue growth estimate for FY27 to 9.3% (earlier ~12.6%) and increased the EBIT margin estimate for FY27 and FY28 to 15.5% (earlier ~13.6%). This has led to a 10%/12% increase in earnings per share (EPS).

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Outlook and Valuation

We maintain our BUY recommendation on Coforge due to its attractive valuations. We value the company at 25x on FY28E EPS of ~INR 66, leading to a revised target price (TP) of INR 1,660. An increase in the valuation multiple going forward is contingent on an improvement in the company's organic growth trajectory.

EstimatePreviousRevised
Organic Revenue Growth (FY27)~12.6%9.3%
EBIT Margin (FY28)~13.6%15.5%
EBIT Margin (FY27)~13.6%15.5%
EPS Growth10%/12%

Investor Takeaway

ICICI Securities recommends buying Coforge stock with a target price of Rs 1660.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.